Also trades as: ALPMY (OTC) · $vol 2M · ALPMF (OTC) · $vol 0M

¥2,230.50 ($14.12)

-14.50 (-0.65%)

Weekly Expected Move ±3.3%

¥2097 ¥2171 ¥2245 ¥2319 ¥2393

JPX · Healthcare · Drug Manufacturers - General · Tech Score Neutral · Power 47 · ¥4.02T mcap · 1.79B float · 0.363% daily turnover

Revenue

$2.14T +11.9% ▲

5Y CAGR: +11.4%

Gross Profit

$1.59T +2.0% ▲

5Y CAGR: +9.7%

Operating Income

$419.7B +64.2% ▲

5Y CAGR: +10.8%

Net Income

$291.5B +474.5% ▲

5Y CAGR: +19.3%

EPS (Diluted)

$162.22 +474.4% ▲

5Y CAGR: +20.1%

EBITDA

$585.3B +26.5% ▲

5Y CAGR: +21.6%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$1.30T	$1.52T	$1.60T	$1.91T	$2.14T
YoY Growth	+3.7%	+17.2%	+5.6%	+19.2%	+11.9%
Cost of Revenue	$253.0B	$288.4B	$292.5B	$349.2B	$544.4B
Gross Profit	$1.04T	$1.23T	$1.31T	$1.56T	$1.59T
Gross Margin	80.5%	81.0%	81.8%	81.7%	74.6%
R&D Expenses	$246.0B	$276.1B	$294.2B	$327.7B	$314.8B
SG&A Expenses	$548.8B	$630.3B	$740.1B	$843.0B	$860.3B
Operating Expenses	$823.1B	$944.8B	$1.13T	$1.31T	$1.18T
Operating Income	$220.0B	$285.4B	$178.1B	$255.7B	$419.7B
Operating Margin	17.0%	18.8%	11.1%	13.4%	19.6%
Interest Expense	$4.9B	$8.8B	$9.4B	$17.7B	$14.1B
Income Before Tax	$156.9B	$132.4B	$25.0B	$31.2B	$376.6B
Tax Expense	$32.8B	$33.6B	$7.9B	-$19.5B	$85.0B
Net Income	$124.1B	$98.7B	$17.0B	$50.7B	$291.5B
Net Margin	9.6%	6.5%	1.1%	2.7%	13.6%
EPS (Diluted)	$67.05	$54.09	$9.47	$28.24	$162.22
EBITDA	$241.0B	$240.5B	$195.3B	$462.7B	$585.3B
Shares Outstanding	1.85B	1.83B	1.80B	1.80B	1.80B

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$473.1B	$462.5B	$517.4B	$459.3B	$505.8B	$524.3B	$571.2B	$537.9B
Cost of Revenue	$91.1B	$116.9B	$98.5B	$76.9B	$94.8B	$138.3B	$149.1B	$129.4B
Gross Profit	$382.0B	$345.6B	$418.9B	$382.4B	$411.0B	$386.1B	$422.1B	$408.5B
Gross Margin	80.7%	74.7%	81.0%	83.3%	81.3%	73.6%	73.9%	75.9%
R&D Expenses	$86.8B	$85.5B	$79.1B	$76.3B	$71.7B	$71.6B	$75.6B	$95.9B
SG&A Expenses	$206.9B	$199.5B	$225.3B	$211.3B	$197.0B	$206.8B	$221.8B	$234.7B
Operating Expenses	$331.3B	$285.0B	$535.1B	$104.3B	$316.3B	$278.4B	$297.4B	$330.6B
Operating Income	$53.3B	$60.5B	-$116.2B	$278.2B	$94.6B	$107.6B	$124.7B	$77.9B
Operating Margin	11.3%	13.1%	-22.5%	60.6%	18.7%	20.5%	21.8%	14.5%
Interest Expense	$4.5B	$5.0B	$4.2B	$3.9B	$5.9B	$2.7B	$2.4B	$3.0B
Income Before Tax	$50.5B	$38.5B	-$118.4B	$60.6B	$90.4B	$104.2B	$134.0B	$48.0B
Tax Expense	$12.9B	$2.6B	-$20.7B	-$14.3B	$22.0B	$25.0B	$33.6B	$4.4B
Net Income	$37.6B	$35.9B	-$97.7B	$74.9B	$68.4B	$79.2B	$100.3B	$43.6B
Net Margin	7.9%	7.8%	-18.9%	16.3%	13.5%	15.1%	17.6%	8.1%
EPS (Diluted)	$20.94	$19.94	$-54.57	$41.84	$38.11	$44.06	$55.85	$24.20
EBITDA	$103.3B	$94.1B	$126.1B	$132.8B	$151.8B	$154.2B	$185.6B	$101.4B
Shares Outstanding	1.80B	1.80B	1.79B	1.79B	1.80B	1.80B	1.80B	1.80B

4503.T JPX